<DOC>
	<DOCNO>NCT00132613</DOCNO>
	<brief_summary>The purpose study evaluate efficacy pericardial instillation bleomycin sclerosing agent pericardial drainage lung cancer-associated malignant pericardial effusion .</brief_summary>
	<brief_title>Trial Drainage With Without Bleomycin Instillation Malignant Pericardial Effusion</brief_title>
	<detailed_description>Malignant pericardial effusion ( MPEs ) , commonly associate cardiac tamponade , make oncologic emergency require prompt drainage . In lung cancer patient , MPE one unpleasant terminal event . Drainage usually result prompt palliation symptom , recurrent effusion often occur . Sclerosis pericardial instillation various agent report prevent recurrence , bleomycin commonly use drug , few toxicity compare others . There , however , prospective trial pericardial sclerosis compare drainage alone MPEs , far clear whether sclerosis really benefit patient terminal stage . Comparison : Intra-pericardial instillation bleomycin pericardial drainage versus drainage alone MPEs cause lung cancer .</detailed_description>
	<mesh_term>Pericardial Effusion</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Pathologically document lung cancer Clinically stable condition pericardial drainage malignant pericardial effusion ( necessary document cytology ) Expected live 6 week longer Sufficient organ function Signed informed consent Myocardial infarction unstable angina within 3 month Constrictive pericarditis Active pneumonitis Severe infection disseminate intravascular coagulation ( DIC ) Other severe comorbidity could relieve pericardial drainage Chemotherapynaive small cell lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>pulmonary neoplasm</keyword>
	<keyword>malignant pericardial effusion</keyword>
	<keyword>pericardial drainage</keyword>
	<keyword>randomize trial</keyword>
	<keyword>bleomycin</keyword>
	<keyword>intrapericardial instillation</keyword>
</DOC>